Defunding Scientific Research: Implications and...

By João L. Carapinha

April 25, 2025

“The Cost of Defunding Scientific Research,” written by Atul Gawande, argues that the Trump Administration’s threatened federal funding cuts to Harvard and affiliated hospitals would have catastrophic effects on American scientific research, patie...
Navigating Drug Price Regulation: Evaluating the Executive Order’s Pote...
Capivasertib Cost-Effectiveness in Advanced Breast Cancer
Toripalimab Evidence Journey in Cancer Care
Cancer Control Month 2025: Key Takeaways from President Trump’s National Call...
Neoadjuvant Chemoimmunotherapy HNSCC in Advanced HPV-Negative Patients
Prior Authorization Elimination: Is Optum Rx moving towards Access Efficiency?
Pharmaceutical Innovation and Market Access: Insights from Fast Company’s 202...
Enhancing Colorectal Cancer Screening Through Mail and Navigation Strategies
Journavx Market Access Strategy in Focus: What Early Payer Decisions Signal f...
NovoCare and the Rise of Direct-to-Consumer Pharmaceutical Access
AI Moral Decision-Making: Navigating the Complexities of Kidney Allocation De...
Zircaix: A Potential Breakthrough in Kidney Cancer Diagnosis